Actemra 162 MG/0.9 ML syringe 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FVJZX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,600
Award facts
- Contract value 100% obligated
- $3,600.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,600.42 to AmerisourceBergen Drug Corp for the supply of ACTEMRA 162 mg/0.9 mL syringes on July 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of July 29, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX contract enables the company to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. This delivery order for ACTEMRA, a rheumatoid arthritis and other immunologic condition treatment, represents a routine fulfillment under AmerisourceBergen's established pharmaceutical prime vendor relationship with DLA.
Quick answers
Who was awarded contract SPE2DB25FVJZX?
SPE2DB25FVJZX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FVJZX worth?
The government has obligated $3,600 on SPE2DB25FVJZX.
Is contract SPE2DB25FVJZX an order under another contract?
Yes. SPE2DB25FVJZX is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVJZX competed?
The extent of competition for SPE2DB25FVJZX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award